BABA vs STRO
Alibaba Group Holding Ltd (BABA) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
BABA currently screens at market cap $305.19B and trailing P/E 19.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the BABA and STRO stock pages for the full models.
Not investment advice.